Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Medtronic PLC    MDT   IE00BTN1Y115

MEDTRONIC PLC (MDT)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Medtronic : NPPA SENDS MIXED SIGNALS WITH NOD FOR ABBOTT STENT WITHDRAWAL

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/28/2017 | 02:00am CEST

The National Pharmaceutical Pricing Authority (NPPA) has allowed Abbott Healthcare to discontinue its drug-eluting stent, Alpine, from the Indian market - a decision that is sending mixed signals to the market. The NPPA has already permitted Abbott to withdraw its dissolvable stent, Absorb, from the market. NPPA's move has raised concerns over a 'sudden shortage' of cardiac stents in the market. NPPA has brought cardiac stents under price control and reduced the price of a drug-coated stent to Rs30,000 from Rs1.5- 1.9 lakh earlier. However, companies like Abbott and Medtronic have decided to withdraw some of their top drug-eluting stents from the Indian market as their margins would get hit.

Copyright (c) 2017 . Informatics India Ltd., source Indian Business Insight

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDTRONIC PLC
07/20MEDTRONIC : Clinical Trial to Evaluate ECG Belt for Optimizing Heart Failure The..
AQ
07/19MEDTRONIC : Research Conducted at Medtronic Has Provided New Information about C..
AQ
07/19MEDTRONIC : Clinical Trial to Evaluate ECG Belt for Optimizing Heart Failure The..
AQ
07/19MEDTRONIC : MILITARY $237,000 Federal Contract Awarded to Medtronic Sofamor Dane..
AQ
07/18Free Technical Research on Medtronic and Three More Medical Equipment Equitie..
AC
07/16MEDTRONIC : Wins Expanded Indication for SelectSecure MRI SureScan Pacing Lead f..
AQ
07/13MEDTRONIC : Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure
AQ
07/12MEDTRONIC : Wins Expanded Indication for SelectSecure(TM) MRI SureScan(TM) Pacin..
AQ
07/12MEDTRONIC : Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure
AQ
07/12MEDTRONIC : First-Year Results from Medtronic and UnitedHealthcare Value-Based R..
AQ
More news
News from SeekingAlpha
07/22THE PASSIVE DGI CORE PORTFOLIO : Midyear Review 
07/21STOCKS TO WATCH : FANGs Out In Tech 
07/20QUARTERLY REVIEW OF DIVGRO : Q2 2018 
07/19My Dividend Growth Portfolio - Q2 2018 Summary 
07/18INTUITIVE SURGICAL : Potentially Attractive Entry Point Following Any Post-2Q18 .. 
Financials ($)
Sales 2019 30 597 M
EBIT 2019 8 808 M
Net income 2019 5 032 M
Debt 2019 10 521 M
Yield 2019 2,22%
P/E ratio 2019 24,18
P/E ratio 2020 21,21
EV / Sales 2019 4,25x
EV / Sales 2020 3,98x
Capitalization 120 B
Chart MEDTRONIC PLC
Duration : Period :
Medtronic PLC Technical Analysis Chart | MDT | IE00BTN1Y115 | 4-Traders
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 94,6 $
Spread / Average Target 7,5%
EPS Revisions
Managers
NameTitle
Omar S. Ishrak Chairman & Chief Executive Officer
Mark Ploof Senior Vice President-Global Operations
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Richard E. Kuntz Chief Scientific, Clinical & Regulatory Officer
Richard H. Anderson Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MEDTRONIC PLC9.00%119 518
BAXTER INTERNATIONAL16.03%40 196
ALIGN TECHNOLOGY68.95%29 681
ZIMMER BIOMET HOLDINGS-7.47%22 815
HOYA CORPORATION14.16%22 301
TERUMO CORP16.73%21 287